Abstract
Hemophilia A (HA) is the most common severe bleeding disorder in humans, affecting one in 5,000 male births. In severe HA, intron 22 inversion of F8 is the most prevalent mutation, accounting for 40–50% of all mutations; however, little is known about the disease-causing mutations among Egyptian hemophiliacs. We aimed at genotyping all possible known DNA rearrangements of intron 22 of F8 in Egyptian HA patients. Peripheral blood samples were collected from 30 Egyptian HA patients (13 severe, ten moderate, and seven mild cases). Genotyping of F8 intron 22 rearrangements was performed by inverse-shifting PCR (IS-PCR). Our study revealed that seven patients (23.3%) had inversion 22, three patients (10%) had deletion 22, and 20 patients (66.7%) carried the wild-type allele. No intron 22 duplication was detected. The relative proportion of inversion 22-type 1 to inversion 22-type 2 was 85.7% and 14.3%, respectively, whereas the relative proportion of deletion 22-type 1 to deletion 22-type 2 was 33.3% and 66.7%, respectively. A statistically highly significant relation was found between disease severity and F8 intron 22 rearrangements (p = 0.008). Among severe cases, 46.1% had inversion 22, 23.1% had deletion 22, and 30.8% carried the wild-type allele. We conclude that F8 intron 22 inversion/deletion is responsible for about one third of disease-causing mutations among Egyptian hemophiliacs and for nearly 70% in severe cases. In addition, F8 intron 22 inversion/deletion by IS-PCR has proven to be a rapid and robust technique and might be the recommended tool for genetic analysis of HA patients specially with severe cases in developing countries.
Similar content being viewed by others
References
Jandle JH (1996) Disorders of coagulation. In: Jandle JH (ed) Blood textbook of hematology, 2nd edn. Little Brown and Company, Boston, pp 1361–1366
Gab-Allah MR, Ahmed BM (1990) Prevalence of hereditary hemorrhagic blood disorders among adult Egyptian males. New Egypt J Med 4:823–824
Kazazian HH, Tuddenham EGD, Antonarakis SE (2001) Hemophilia A: deficiency of coagulation factor VIII. In: Baudette AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 4367–4392
Lakich D, Kazazian HH Jr, Antonarakis SE, Gitschier J (1993) Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat Genet 5:236–241
Bagnall RD, Giannelli F, Green PM (2006) Int22h-related inversions causing hemophilia A: a novel insight into their origin and a new more discriminant PCR test for their detection. J Thromb Haemost 4:591–598
Hussein IR, El-Beshlawy A, Salem A, Mosaad R, Zaghloul N, Ragab L, Fayek H, Gaber K, El-Ekiabi M (2008) The use of DNA markers for carrier detection and prenatal diagnosis of haemophilia A in Egyptian families. Haemophilia 14:1082–1087
Rossetti LC, Radic CP, Larripa IB, De Brasi CD (2008) Developing a new generation of tests for genotyping hemophilia-causative rearrangements involving int22h and int1h hotspots in the factor VIII gene. J Thromb Haemost 6:830–836
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Rossetti LC, Radic CP, Larripa IB, De Brasi CD (2005) Genotyping the hemophilia inversion hotspot by use of inverse PCR. Clin Chem 51:1154–1158
Liu Q, Sommer SS (1998) Subcycling-PCR for multiplex long-distance amplification of regions with high and low GC content: application to the inversion hotspot in the factor VIII gene. Biotechniques 25:1022–1028
Rossiter JP, Young M, Kimberland ML, Hutter P, Ketterling RP, Gitschier J, Horst J, Morris MA, Schaid DJ, de Moerloose P et al (1994) Factor VIII gene inversions causing severe hemophilia A originate almost exclusively in male germ cells. Hum Mol Genet 3:1035–1039
Naylor JA, Buck D, Green P, Williamson H, Bentley D, Giannelli F (1995) Investigation of the factor VIII intron 22 repeated region (int22h) and the associated inversion junctions. Hum Mol Genet 4:1217–1224
Chen YC, Hu SH, Cheng SN, Chao TY (2010) Genetic analysis of haemophilia A in Taiwan. Haemophilia 16:538–544
Keeney S, Mitchell M, Goodeve A (2005) The molecular analysis of haemophilia A: a guideline from the UK haemophilia centre doctors’ organization haemophilia genetics laboratory network. Haemophilia 11:387–397
Oldenburg J, Ananyeva NM, Saenko EL (2004) Molecular basis of haemophilia A. Haemophilia 10(Suppl 4):133–139
Liu Q, Nozari G, Sommer SS (1998) Single-tube polymerase chain reaction for rapid diagnosis of the inversion hotspot of mutation in hemophilia A. Blood 92:1458–1459
Antonarakis SE, Rossiter JP, Young M, Horst J, de Moerloose P, Sommer SS, Ketterling RP, Kazazian HH Jr, Négrier C, Vinciguerra C et al (1995) Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood 86:2206–2212
Soares RP, Chamone DA, Bydlowski SP (2001) Factor VIII gene inversions and polymorphisms in Brazilian patients with haemophilia A: carrier detection and prenatal diagnosis. Haemophilia 7:299–305
Andrikovics H, Klein I, Bors A, Nemes L, Marosi A, Váradi A, Tordai A (2003) Analysis of large structural changes of the factor VIII gene, involving intron 1 and 22, in severe hemophilia A. Haematologica 88:778–784
Jenkins PV, Collins PW, Goldman E, McCraw A, Riddell A, Lee CA, Pasi KJ (1994) Analysis of intron 22 inversions of the factor VIII gene in severe hemophilia A: implications for genetic counseling. Blood 84:2197–2201
Jayandharan G, Shaji RV, George B, Chandy M, Srivastava A (2004) Informativeness of linkage analysis for genetic diagnosis of haemophilia A in India. Haemophilia 10:553–559
Abu-Amero KK, Hellani A, Al-Mahed M, Al-Sheikh I (2008) Spectrum of factor VIII mutations in Arab patients with severe haemophilia A. Haemophilia 14:484–488
Laurie AD, Sheen CR, Hanrahan V, Smith MP, George PM (2007) The molecular aetiology of haemophilia A in a New Zealand patient group. Haemophilia 13:420–427
Lin SR, Chang SC, Lee CC, Shen MC, Lin SW (1995) Genetic diagnosis of haemophilia A of Chinese origin. Br J Haematol 91:722–727
Inaba H, Shibata H, Yoshida S, Hagiwara T, Hanabusa H, Nagao T, Fukutake K (1995) Inversion in Japanese patients with hemophilia A. Thromb Haemost 74:810
Castaman G, Giacomelli SH, Ghiotto R, Boseggia C, Pojani K, Bulo A, Madeo D, Rodeghiero F (2007) Spectrum of mutations in Albanian patients with haemophilia A: identification of ten novel mutations in the factor VIII gene. Haemophilia 13:311–316
Castaldo G, D’Argenio V, Nardiello P, Zarrilli F, Sanna V, Rocino A, Coppola A, Di Minno G, Salvatore F (2007) Haemophilia A: molecular insights. Clin Chem Lab Med 45:450–461
Rossetti LC, Radic CP, Candela M, Pérez Bianco R, de Tezanos PM, Goodeve A, Larripa IB, De Brasi CD (2007) Sixteen novel hemophilia A causative mutations in the first Argentinian series of severe molecular defects. Haematologica 92:842–845
Poláková H, Kádasi L, Filová A (1998) Analysis of inversion in intron 22 of the factor F VIII:C gene in patients with hemophilia A in the Slovak population. Bratisl Lek Listy 99:538–542
Margaglione M, Castaman G, Morfini M, Rocino A, Santagostino E, Tagariello G, Tagliaferri AR, Zanon E, Bicocchi MP, Castaldo G, AICE-Genetics Study Group et al (2008) The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype. Haematologica 93:722–728
Goodeve AC, Peake IR (2003) The molecular basis of hemophilia A: genotype–phenotype relationships and inhibitor development. Semin Thromb Hemost 29:23–30
Kulkarni R, Ponder KP, James AH, Soucie JM, Koerper M, Hoots WK, Lusher JM (2006) Unresolved issues in diagnosis and management of inherited bleeding disorders in the perinatal period: a White Paper of the Perinatal Task Force of the Medical and Scientific Advisory Council of the National Hemophilia Foundation, USA. Haemophilia 12:205–211
Leuer M, Oldenburg J, Lavergne JM, Ludwig M, Fregin A, Eigel A, Ljung R, Goodeve A, Peake I, Olek K (2001) Somatic mosaicism in hemophilia A: a fairly common event. Am J Hum Genet 69:75–87
Oldenburg J, Rost S, El-Maarri O, Leuer M, Olek K, Müller CR, Schwaab R (2000) De novo factor VIII gene intron 22 inversion in a female carrier presents as a somatic mosaicism. Blood 96:2905–2906
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abou-Elew, H., Ahmed, H., Raslan, H. et al. Genotyping of intron 22-related rearrangements of F8 by inverse-shifting PCR in Egyptian hemophilia A patients. Ann Hematol 90, 579–584 (2011). https://doi.org/10.1007/s00277-010-1115-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-010-1115-x